These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32304704)

  • 1. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma.
    Farah M; Reuben A; Spassova I; Yang RK; Kubat L; Nagarajan P; Ning J; Li W; Aung PP; Curry JL; Torres-Cabala CA; Hudgens CW; Ugurel S; Schadendorf D; Gumbs C; Little LD; Futreal A; Wistuba II; Prieto VG; Wang L; Wong MK; Wargo JA; Becker JC; Tetzlaff MT
    J Invest Dermatol; 2020 Nov; 140(11):2146-2156.e4. PubMed ID: 32304704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
    Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
    Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma.
    Feldmeyer L; Hudgens CW; Ray-Lyons G; Nagarajan P; Aung PP; Curry JL; Torres-Cabala CA; Mino B; Rodriguez-Canales J; Reuben A; Chen PL; Ko JS; Billings SD; Bassett RL; Wistuba II; Cooper ZA; Prieto VG; Wargo JA; Tetzlaff MT
    Clin Cancer Res; 2016 Nov; 22(22):5553-5563. PubMed ID: 27166398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
    Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
    J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
    Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
    Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune readouts may have prognostic value for the course of merkel cell carcinoma, a virally associated disease.
    Buck CB; Lowy DR
    J Clin Oncol; 2011 Apr; 29(12):1506-8. PubMed ID: 21422431
    [No Abstract]   [Full Text] [Related]  

  • 9. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
    Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
    Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.
    Behr DS; Peitsch WK; Hametner C; Lasitschka F; Houben R; Schönhaar K; Michel J; Dollt C; Goebeler M; Marx A; Goerdt S; Schmieder A
    Int J Clin Exp Pathol; 2014; 7(11):7610-21. PubMed ID: 25550797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study.
    Paulson KG; Iyer JG; Simonson WT; Blom A; Thibodeau RM; Schmidt M; Pietromonaco S; Sokil M; Warton EM; Asgari MM; Nghiem P
    Am J Clin Pathol; 2014 Oct; 142(4):452-8. PubMed ID: 25239411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells have prognostic value in Merkel cell carcinoma.
    Beer TW; Ng LB; Murray K
    Am J Dermatopathol; 2008 Feb; 30(1):27-30. PubMed ID: 18212540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of American Joint Committee on Cancer T category for eyelid carcinoma with outcomes in patients with periocular Merkel cell carcinoma.
    Sniegowski MC; Warneke CL; Morrison WH; Nasser QJ; Frank SJ; Pfeiffer ML; El-Sawy T; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2014; 30(6):480-5. PubMed ID: 24841735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γδ T Cells in Merkel Cell Carcinomas Have a Proinflammatory Profile Prognostic of Patient Survival.
    Gherardin NA; Waldeck K; Caneborg A; Martelotto LG; Balachander S; Zethoven M; Petrone PM; Pattison A; Wilmott JS; Quiñones-Parra SM; Rossello F; Posner A; Wong A; Weppler AM; Shannon KF; Hong A; Ferguson PM; Jakrot V; Raleigh J; Hatzimihalis A; Neeson PJ; Deleso P; Johnston M; Chua M; Becker JC; Sandhu S; McArthur GA; Gill AJ; Scolyer RA; Hicks RJ; Godfrey DI; Tothill RW
    Cancer Immunol Res; 2021 Jun; 9(6):612-623. PubMed ID: 33674358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
    Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
    Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell carcinomas infiltrated with CD33
    Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
    J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of antibodies to Merkel cell polyomavirus T antigens and VP1 protein in patients with Merkel cell carcinoma.
    Samimi M; Molet L; Fleury M; Laude H; Carlotti A; Gardair C; Baudin M; Gouguet L; Maubec E; Avenel-Audran M; Esteve E; Wierzbicka-Hainaut E; Beneton N; Aubin F; Rozenberg F; Dupin N; Avril MF; Lorette G; Guyetant S; Coursaget P; Touzé A
    Br J Dermatol; 2016 Apr; 174(4):813-22. PubMed ID: 26600395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
    Foote M; Veness M; Zarate D; Poulsen M
    J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Merkelcell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome.
    Haymerle G; Janik S; Fochtmann A; Pammer J; Schachner H; Nemec L; Mildner M; Houben R; Grasl MC; Erovic BM
    PLoS One; 2017; 12(8):e0180426. PubMed ID: 28763479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.